Araim Pharmaceuticals

About:

Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases.

Website: http://araimpharma.com

Description:

Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases. Its lead compound, ARA 290, a novel 11 amino acid peptide, stimulates tissue protective, reparative, and anti-inflammatory signaling pathways through selective IRR activation. Araim Pharmaceuticals is based in Tarrytown, New York.

Total Funding Amount:

$4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tarrytown, New York, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)araimpharma.com

Founders:

Anthony Cerami, Michael Brines

Number of Employees:

1-10

Last Funding Date:

2014-11-17

IPO Status:

Private

Industries: